E(
Therapeutic Areas
Galectin Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Belapectin (GR-MD-02) | MASH Cirrhosis with Portal Hypertension | Phase 2b/3 |
Leadership Team at Galectin Therapeutics
JL
Joel Lewis
President & CEO
PF
Pol F. Boudes, MD
Chief Medical Officer
HB
Henry Brem, M.D.
Board of Directors